Heterogeneity in tuberculosis. (Q38665662)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736436%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

Heterogeneity in tuberculosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736436%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

0 references

1 reference

Anthony M Cadena

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736436%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Sarah M Fortune

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736436%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

JoAnne L Flynn

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736436%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

24 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736436%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Immunology

25 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736436%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736436%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736436%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

691-702

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736436%20AND%20SRC:MED&resulttype=core&format=json

Latent Mycobacterium tuberculosis infection

25 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Understanding latent tuberculosis: a moving target

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The spectrum of latent tuberculosis: rethinking the biology and intervention strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Eliminating latent tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

ExperimentalMycobacterium tuberculosisInfection of Cynomolgus Macaques Closely Resembles the Various Manifestations of HumanM. tuberculosisInfection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The human immune response to tuberculosis and its treatment: a view from the blood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Advances in the development of new tuberculosis drugs and treatment regimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The challenge of new drug discovery for tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Host immune transcriptional profiles reflect the variability in clinical disease manifestations in patients with Staphylococcus aureus infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

A blood RNA signature for tuberculosis disease risk: a prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Early Whole Blood Transcriptional Signatures Are Associated with Severity of Lung Inflammation in Cynomolgus Macaques with Mycobacterium tuberculosis Infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Granulomatous inflammation--a review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Foamy macrophages and the progression of the human tuberculosis granuloma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Macrophages and control of granulomatous inflammation in tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The role of the granuloma in expansion and dissemination of early tuberculous infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Revisiting the role of the granuloma in tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Mutual attraction: does it benefit the host or the bug?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The immune response in tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Lesion-Specific Immune Response in Granulomas of Patients with Pulmonary Tuberculosis: A Pilot Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Early Changes by (18)Fluorodeoxyglucose positron emission tomography coregistered with computed tomography predict outcome after Mycobacterium tuberculosis infection in cynomolgus macaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The Importance of First Impressions: Early Events in Mycobacterium tuberculosis Infection Influence Outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Genomic diversity in autopsy samples reveals within-host dissemination of HIV-associated Mycobacterium tuberculosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Role of innate cytokines in mycobacterial infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The innate immune response in human tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Early events in Mycobacterium tuberculosis infection in cynomolgus macaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Inflammatory signaling in human tuberculosis granulomas is spatially organized

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Multiscale computational modeling reveals a critical role for TNF-α receptor 1 dynamics in tuberculosis granuloma formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Modeling the Mycobacterium tuberculosis Granuloma - the Critical Battlefield in Host Immunity and Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The immunological life cycle of tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

PET CT Identifies Reactivation Risk in Cynomolgus Macaques with Latent M. tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Dying to live: how the death modality of the infected macrophage affects immunity to tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Advancing host-directed therapy for tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The balance between protective and pathogenic immune responses in the TB-infected lung

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Multi-scale modeling predicts a balance of tumor necrosis factor-α and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Computational modeling predicts IL-10 control of lesion sterilization by balancing early host immunity-mediated antimicrobial responses with caseation during mycobacterium tuberculosis infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Beyond macrophages: the diversity of mononuclear cells in tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Macrophages in tuberculosis: friend or foe.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Innate Immune Defenses in Human Tuberculosis: An Overview of the Interactions between Mycobacterium tuberculosis and Innate Immune Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Digitally Barcoding Mycobacterium tuberculosis Reveals In Vivo Infection Dynamics in the Macaque Model of Tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Macrophage Epithelial Reprogramming Underlies Mycobacterial Granuloma Formation and Promotes Infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Computational and Empirical Studies Predict Mycobacterium tuberculosis-Specific T Cells as a Biomarker for Infection Outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Mathematical and computational approaches can complement experimental studies of host-pathogen interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Tuneable resolution as a systems biology approach for multi-scale, multi-compartment computational models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Mycobacterium tuberculosis strains of the modern sublineage of the Beijing family are more likely to display increased virulence than strains of the ancient sublineage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Mycobacterium tuberculosis Strains Are Differentially Recognized by TLRs with an Impact on the Immune Response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Modelling within-host spatiotemporal dynamics of invasive bacterial disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Bottlenecks in HIV-1 transmission: insights from the study of founder viruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Inferring patient to patient transmission of Mycobacterium tuberculosis from whole genome sequencing data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

How sisters grow apart: mycobacterial growth and division

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Dynamic persistence of antibiotic-stressed mycobacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Nonreplicating persistence of mycobacterium tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Acid-Fast Positive and Acid-Fast Negative Mycobacterium tuberculosis: The Koch Paradox.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Cell-wall alterations as an attribute of Mycobacterium tuberculosis in latent infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Resuscitation-promoting factors reveal an occult population of tubercle Bacilli in Sputum.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Patients with Tuberculosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Stress and host immunity amplify Mycobacterium tuberculosis phenotypic heterogeneity and induce nongrowing metabolically active forms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Nitroimidazoles for the treatment of TB: past, present and future

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Diarylquinolines target subunit c of mycobacterial ATP synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Inhibiting Mycobacterium tuberculosis within and without

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The association between sterilizing activity and drug distribution into tuberculosis lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The Zebrafish Breathes New Life into the Study of Tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Modeling tuberculosis in nonhuman primates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Immunology studies in non-human primate models of tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Monkey models of tuberculosis: lessons learned

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

CD4 T cell depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent infection is dependent on severity of tissue depletion in cynomolgus macaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Human TOLLIP regulates TLR2 and TLR4 signaling and its polymorphisms are associated with susceptibility to tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

A Functional Toll-Interacting Protein Variant Is Associated with Bacillus Calmette-Guérin-Specific Immune Responses and Tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Genetic dissection of immunity to mycobacteria: the human model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Toll-like receptor polymorphisms and susceptibility to human disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The Collaborative Cross, a community resource for the genetic analysis of complex traits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

The genome architecture of the Collaborative Cross mouse genetic reference population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2017.69

Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications

31 March 2020

1 reference

12 December 2020

A bacteriologic study of resected tuberculous lesions

1 reference

12 December 2020

Some clinical features of tuberculosis

1 reference

12 December 2020

Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model

1 reference

12 December 2020

The curious characteristics of pyrazinamide: a review

1 reference

12 December 2020

The spectrum of human tuberculosis

1 reference

12 December 2020

How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis

1 reference

12 December 2020

A study of the tubercle bacillus in resected pulmonary lesions.

1 reference

12 December 2020

The bacteriology of resected tuberculous pulmonary lesions. I. The effect of interval between reversal of infectiousness and subsequent surgery

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRI.2017.69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736436%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736436%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

PubMed publication ID

28736436

1 reference